-+ 0.00%
-+ 0.00%
-+ 0.00%

Teladoc Health Narrows FY2025 GAAP EPS Guidance from $(1.35)-$(1.00) to $(1.25)-$(1.10) vs $(1.12) Est; Narrows FY2025 Sales Guidance from $2.501B-$2.548B to $2.510B-$2.539B vs $2.522B Est

Benzinga·10/29/2025 20:09:54
Listen to the news
Teladoc Health (NYSE:TDOC) narrows FY2025 GAAP EPS guidance from $(1.35)-$(1.00) to $(1.25)-$(1.10) vs $(1.12) analyst estimate. Narrows FY2025 sales outlook from $2.501 billion-$2.548 billion to $2.510 billion-$2.539 billion vs $2.522 billion estimate.